LAS VEGAS, March 26, 2015 /PRNewswire/ -- Zimmer Holdings,
Inc. (NYSE and SIX: ZMH) is highlighting its
Vivacit-E® Advanced Bearing Technology
with Vitamin E by celebrating a significant testing milestone.
A paper published earlier this month reported that, at 96
million cycles of in vitro wear testing, Vivacit-E Advanced
Bearing Technology featuring Vitamin E grafted highly crosslinked
polyethylene hip acetabular liners from Zimmer maintained a
significant wear rate reduction of 95 percent, with no cracking,
delamination or fracture observed on the samples
evaluated1.
"As patients for total hip replacements continue to skew younger
and more active, it's more important than ever to provide them a
product that offers proven, low-wear stability and durability, and
that's exactly what Vivacit-E Technology does," said
Matt Monaghan, Zimmer Senior Vice
President and General Manager, Hips. "By offering a lifetime of
wear resistance and the prevention of long-term oxidation,
Vivacit-E Advanced Bearing Technology plays a crucial role
in making hip replacement technology from Zimmer the industry
standard."
Zimmer's Vivacit-E Vitamin E Technology has been lab
tested to mimic the number of walking steps an implant will
typically be subjected to during its lifetime. Based on the average
American life expectancy of 78.7 years, a patient who undergoes hip
replacement at the age of 45 would need their implant to last for
34 years.2 Depending on how active a person is, studies
have shown that we typically take about 1.1 - 2.2 million walking
steps per year. Therefore, the implant would be subjected to
between 37 - 74 million steps during its
lifetime.3,4
"Because of this incredible longevity and durability,
Vivacit-E Liners help make this hip replacement technology
the implant of choice for younger and more active patients,"
Monaghan added.
About the Company
Founded in 1927 and headquartered
in Warsaw, Indiana, Zimmer
designs, develops, manufactures and markets orthopaedic
reconstructive, spinal and trauma devices, dental implants, and
related surgical products. Zimmer has operations in more than
25 countries around the world and sells products in more than 100
countries. Zimmer's 2014 sales were approximately
$4.7 billion. The Company
is supported by the efforts of more than 9,000 employees
worldwide. More information about Zimmer is available at
www.zimmer.com.
Cautionary Statement Regarding Forward-Looking
Statements
This press release contains forward-looking
statements within the meaning of the safe harbor provisions of the
Private Securities Litigation Reform Act of 1995. Such
statements are based upon the current beliefs and expectations of
Zimmer's management and are subject to significant risks and
uncertainties that could cause actual outcomes and results to
differ materially. These risks and uncertainties include, but
are not limited to: future test results or patient experiences
being inconsistent with test findings to date; actions of
regulatory bodies or other governmental authorities; changes in
laws and regulations; competitive developments; and other risks and
uncertainties described in Zimmer's periodic reports filed with the
U.S. Securities and Exchange Commission. Zimmer disclaims any
intention or obligation to update or revise any forward-looking
statements, whether as a result of new information, future events
or otherwise, except as may be set forth in Zimmer's periodic
reports. Readers of this communication are cautioned not to
place undue reliance on these forward-looking statements, since,
while management believes the assumptions on which the
forward-looking statements are based are reasonable, there can be
no assurance that these forward-looking statements will prove to be
accurate.
References:
- Zimmer Report TTN 1010-001 wear testing conducted per ISO
14242-1.
- Centers for Disease Control and Prevention (13 Feb 2014). Life Expectancy. Retrieved
April 1, 2014 from
http://www.cdc.gov/nchs/fastats/lifexpec.htm.
- Morlock et al. "Duration and frequency of every day activities
in total hip patients." Journal of Biomechanics.
2001;34(7):873-881.
- Kinkel et al. "Patient Activity after Total Hip Arthroplasty
Declines with Advancing Age." CORR. 2009;467:2053-2058.
Logo -
http://photos.prnewswire.com/prnh/20131216/MM33947LOGO
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/zimmer-announces-new-testing-milestone-for-vitamin-e-advanced-bearing-technology-300056439.html
SOURCE Zimmer Holdings, Inc.